Researchers continue to uncover the healing power of cannabis, which is good news for consumers, companies, and investors alike…

Just since October, dozens of researchers have demonstrated the health and wellness benefits of cannabis for migraines, pain, and overall quality of life for those with chronic health conditions – contributing to the already extensive body of research.

A recent study in the Journal of Pain revealed that of participants who experienced migraine headaches, about 50% saw a reduction in pain severity after using cannabis – and those who had used a cannabis concentrate experienced an even higher reduction in pain severity.

Imagine the implications for the cannabis market, particularly in Canada where Cannabis 2.0 will be rolling out over the next few months!

Another study reported that medical cannabis significantly improved health-related quality of life symptoms such as pain, anxiety, depression, and insomnia for people living with chronic conditions.

At least 75% of participants in the study reported that they had used medical cannabis to effectively alleviate two or more of these symptoms.

And I haven’t even touched on the recently-discovered health benefits of CBD.

Folks, these developments have big pharma shaking in their boots…

The Healing Potential of CBD

The use of CBD in relieving a whole host of different health issues has been a hot topic as the impending $22 billion CBD market has absolutely exploded over the past year.

And CBD searches on Google are at an all-time high, indicating that consumers are more interested than ever and actively seeking out information.

Unfortunately, the FDA has not issued any regulatory guidelines for cannabis companies looking to market CBD products for health-related issues. As a result, a handful of companies selling CBD products have been issued warnings for making claims about CBD’s efficacy in treating conditions like ADHD and autism.

But even as the Food and Drug Administration has been slow to release guidelines for CBD, the non-psychoactive compound found in cannabis and hemp has proven over and over again to be an effective way to manage pain and curb the use of opioids, among other things.

In fact, researchers recently demonstrated that hemp extract CBD helped 53% of participants suffering from chronic pain ween off of opioids after 8 weeks – and nearly all of the study’s participants (94%) experienced significant improvements to their quality of life.

And overall, states in which cannabis has been legalized experience less opioid overdose deaths than states where it’s still illegal.

In the wake of the intense opioid crisis in the U.S., the possibility that completely legal hemp-derived CBD can help patients reduce or completely erase the need for opioids is staggering. In 2017 alone the U.S. saw 47,600 opioid-related overdose deaths.

We’ve combined a year’s worth of cannabis investing resources into one invaluable guidebook. Make sure and claim your free copy today – because copies are limited.

CBD is also becoming increasingly popular among athletes as a way to manage pain and promote recovery from sports-related injuries. One study published in October out of Sports Injury and Medicine showed that CBD can be effective in both preventing traumatic brain injuries and as a therapy for those who have suffered one.

And some of the most well-known professional athletes are at the forefront of the CBD movement.

Soccer star, Rachael Rapinoe – twin sister of Megan Rapinoe – recently launched her own CBD business, Mendi, where Megan is a brand ambassador. As a women’s soccer fan myself, I was fortunate enough to interview Rachael about her new business and how she strives to help athletes with her focus on health and wellness.

I invite you to read my exclusive interview with Rachael here.

These CBD Companies Are On the Front Lines

Cannabis companies focused on the health and wellness aspect of cannabis and hemp-derived CBD are in the best position to get their products to patients and consumers in need. And for the companies that are already successfully providing these products, the sky’s the limit in terms of profit potential.

Take Charlotte’s Web Holdings (TSX: CWEB), for example.

Charlotte’s Web is the largest CBD company in the world, in part because its products are made from hemp-derived CBD – meaning that the products can be sold in all 50 states in the U.S. and countries around the world, whether that country has a medical-cannabis program or not.

And the results speak for themselves. The company has grown by about 20% every quarter and by nearly 50% annually!

But not all CBD companies deserve your hard-earned cash.

Which brings me to another one of the biggest names in the United States CBD space, CV Sciences Inc. (OTC: CVSI). Considered by many as a CBD pioneer, CVSI has products on the shelves in major national retailers like CVS and Kroger.

In an industry that is growing as rapidly as CBD, CVSI has still managed to plummet its year-over-year sales by 7% – a massive failing in a thriving market, in part due to a complete lack of branding.

On the surface, these two companies may seem like they’re in a relatively similar position to meet the growing market demand for CBD. But a closer look would reveal anything but.

That’s why I’m here to help you sort out which companies are doing it right, and which are struggling to survive.

What’s most impressive about the potential health benefits of cannabis-based medicine is that we are still learning more each day about the powers behind this plant.

When the federal ban ends, just imagine what we’ll uncover.

With that in mind, keep an eye out for tomorrow’s alert. There’s something brewing in congress that you’re going to want to be aware of…

Until then,

Greg Miller

Executive Director, National Institute for Cannabis Investors

P.S. The influx of CBD products on the market has created an opportunity like we’ve never seen before. Fact is, in the coming year, analysts believe the CBD market alone could grow more than 15 times faster than the cannabis industry as a whole. And we’ve pinpointed two of these CBD companies that could deliver double-, triple-, even quadruple-digit gains practically overnight. Click here to get the full breakdown.


Comments

7 responses to “Evidence of Cannabis Health Benefits Continues to Grow”

  1. Thanks for the regular updates. I have learned a lot from these updates. I am confident that CBD will revolutionize health care. Keep up the good work.

    I am a lifetime member.

  2. Hello Greg,
    What do we know about Health Sense Nutritionals. Their Dr. Olson is
    pushing a product called “CannaEase” ( a CBD) which he says is the best
    on the market for PAIN.

  3. The 53% improvement of opioid users is astounding. Can you tell us who published the study so. that we can cite it?

    Thanks.

  4. In early 1984 I was stationed at Beirut International Airport in Beirut, Lebanon. I was riding in a Marine helicopter that crash-landed at the airport and my back was injured. As I aged the arthritis worsened and the VA’s answer to the immense pain was handfuls of opioids. I retired in 2014 at 57 years old and I’ve been on Social Security and VA disability since 2016. Along with the opioid crisis in the United States the VA started cutting back on veteran opioid usage.
    In the last six months I have been using cbd creams and tinctures to ease the pain no longer hidden behind opioid use. In July in Las Vegas I ran into a cbd cream that has been a life-saver. When I use cbdfx cream my pain disappears and my back feels better than it has in over 35 years.
    Also tinctures I take first thing in the morning and last thing before bed help me get moving in the morning and to sleep through pain at night. While they don’t work as well as the cream they do help. So far I prefer Mary Ruth’s pure hemp tincture.
    I’m not completely off of the tramadal but my usage HAS been cut in half. I can’t tell you how thankful I am for the 2018 farm bill. 🙂

Leave a Reply

Your email address will not be published. Required fields are marked *